A question list to carry

Ask until the answer makes sense.

These prompts leave room for your concern, the source behind an answer, and anything still unclear.

FDA is short for the Food and Drug Administration, which reviews medicines in the US.

The short answer

A good question gives the health professional something to explain. Keep asking for plain words when the answer feels like a label.

Start with the product and the reason

Questions about the proposal

Write below, or use paper. Copy anything worth keeping; the page does not save your notes.

What exactly is being proposed, in what form, and who makes it?Why is it being considered for my concern?What tested options have been considered first?What source can I read for that explanation?

As of September 2026, no US Selank product has FDA approval, so the exact product deserves a clear answer.

The short answer

The small anxiety studies had no comparison group given a look-alike treatment without the medicine being tested.

Such a comparison helps show whether relief comes from the medicine rather than from expecting to feel better. These studies leave that question unanswered.

Ask how the evidence relates to your concern, rather than how many papers exist.

Ask about the parts after the proposal

Questions about the care

Write below, or use paper. Copy anything worth keeping; the page does not save your notes.

What is still unknown about its effects or how it might change the effects of my other medicines?What would the full cost include?Who will be available to answer my questions once the visit ends?What would lead to an in-person assessment?

Keep the answer useful

It answers the question I asked.
It uses words I understand.
It says what is known and what is missing.
It gives a source when I ask for one.

A source worth bringing to the visit

FDA Selank entryGaps in the human safety evidence.Open the evidence note

As of September 2026, important human safety details for Selank are still missing, according to the FDA.

Ask what is known about harm from the exact proposed medicine, and what remains unknown.

Read the FDA Selank entry